Delivery Order SPE2DB20D2104-SPE2DB25FMTAK
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.56 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a $1,756.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is for the supply of 4564736964 ! MENQUADFI VIAL 0.5ML medical products. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.56, is a delivery order for "MENQUADFI VIAL 0.5ML" medical supplies. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a Delivery Order with a Firm Fixed Price contract type valued at $85,619.69, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of MENQUADFI VIAL 0.5ML, a medical product, with a performance period ending on June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the supply of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific order is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $22,854.50 and a completion date of January 12, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $14,049.60 and a period of performance through May 10, 2024. The contract is a firm fixed-price, delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,707.48 and an ultimate completion date of August 5, 2024. The contract is not set aside for a specific business type. AmerisourceBergen, a major U.S. pharmaceutical distributor, is providing these medical supplies to support various government...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565220495 MENQUADFI VIAL 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $3,512.40 and an ultimate completion date of July 23, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,264.50 for the delivery of MENQUADFI VIAL 0.5ML medical products. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This...